Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer
Saved in:
Main Authors: | Ravi A Madan, Christopher Heery, Claudia Palena, Caroline Jochems, Julius Strauss, Marijo Bilusic, Fatima Karzai, Jennifer L Marté, Charalampos Floudas, Peter J DeMaria, Katherine Lee-Wisdom, Angie Schwab, Jason Mark Redman, Eva Dombi, Brigitte Widemann, Borys Korchin, Tatiana Adams, Cesar Pico-Navarro |
---|---|
Format: | article |
Language: | EN |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/37a0f2d29a6c47d6940c4dc1bf5400ca |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genomic targets of Brachyury (T) in differentiating mouse embryonic stem cells.
by: Amanda L Evans, et al.
Published: (2012) -
Mechanism of pyocyanin abolishment caused by mvaT mvaU double knockout in Pseudomonas aeruginosa PAO1
by: Limin Dong, et al.
Published: (2020) -
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
by: Houreratou Barry, et al.
Published: (2021) -
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa
by: Houreratou Barry, et al.
Published: (2021) -
Localization to delocalization probed by magnetotransport of hBN/graphene/hBN stacks in the ultra-clean regime
by: Takuya Iwasaki, et al.
Published: (2021)